Cell Chemical Biology 2018-04-05

Cellular Cyborgs: On the Precipice of a Drug Delivery Revolution

Song Ding, Colin P. O'Banion, Joshua G. Welfare, David S. Lawrence

Index: 10.1016/j.chembiol.2018.03.003

Full Text: HTML

Abstract

Cell-based drug delivery systems offer the prospect of biocompatibility, large-loading capacity, longin vivolifespan, and active targeting of diseased sites. However, these opportunities are offset by an array of challenges, including safeguarding the integrity of the drug cargo and the cellular host, as well as ensuring that drug release occurs at the appropriate time and place. Emerging strategies that address these, and related, issues, are described herein.

Latest Articles:

The Rheumatoid Arthritis-Associated Citrullinome

2018-04-05

[10.1016/j.chembiol.2018.03.002]

Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers

2018-04-05

[10.1016/j.chembiol.2018.03.005]

The O-GlcNAc Transferase Intellectual Disability Mutation L254F Distorts the TPR Helix

2018-03-29

[10.1016/j.chembiol.2018.03.004]

Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling

2018-03-29

[10.1016/j.chembiol.2018.02.012]

Bacterial Alkaloid Biosynthesis: Structural Diversity via a Minimalistic Nonribosomal Peptide Synthetase

2018-03-29

[10.1016/j.chembiol.2018.02.013]

More Articles...